World Sleep Industry ENCYCLOPEDIA

Sleep Literature Review Services

6.5.3

Definition, review types, and evidence boundary

Sleep literature review services define questions, search, select, appraise, synthesize, and report existing research about sleep, circadian rhythms, sleep disorders, measurement technologies, interventions, or industry topics. Products may include narrative, systematic, scoping, rapid, evidence-map, umbrella, and living reviews. Each type answers different questions under different resource and time constraints and supports different conclusions. Using a database or flow diagram does not turn an ordinary compilation of sources into a systematic review.

A systematic review uses prespecified, auditable methods to answer a focused question. A scoping review maps concepts, evidence types, and gaps but does not automatically estimate efficacy. A rapid review trades selected, disclosed shortcuts for timeliness. An umbrella review synthesizes existing reviews and must address overlap in their primary studies. A living review commits to continuing surveillance and timely incorporation of evidence. A narrative review can integrate background and concepts, but its selection process is usually less reproducible. No review can substitute volume of literature for quality of evidence, and a review is not itself a clinical guideline, regulatory conclusion, or personal care recommendation.

Question, protocol, and team governance

Before work begins, the commissioner’s decision need, audience, review type, scope, and intended deliverable should be clear. An appropriate question framework should define population, condition or concept, exposure or intervention, comparator, outcomes, study designs, setting, and time. Sleep duration, insomnia symptoms, respiratory events, stages, fragmentation, sleepiness, and circadian misalignment are not one outcome, and subjective and objective measures should be separated in advance. A feasibility scan can estimate volume, terminology, and existing reviews, but it should not be used to narrow the question silently after results are seen.

Systematic products need a protocol before formal screening or result-driven analysis, specifying eligibility, sources, search, screening, extraction, bias tools, synthesis, subgroups, sensitivity analyses, and certainty methods. The protocol should be publicly registered or archived where eligible. Amendments require dates, reasons, and effects; primary outcomes should not change silently. The team should assign subject, information-retrieval, methods, and statistical roles and disclose funding and conflicts. A service provider can supply research labor and methods support, but authorship, accountability, academic integrity, and publication decisions must reflect actual contributions.

Searching, sources, and record management

The question and eligible study designs should determine bibliographic databases, trial registries, preprints, theses, conference material, regulatory documents, guideline sites, and other grey sources. One search engine is not a complete evidence base. Strategies should combine controlled vocabulary, free text, spelling variants, abbreviations, historical terms, and necessary design terms and be translated into each platform’s syntax. Records should include database and platform, coverage, complete query, filters, run date, and yield. Restrictions by language, year, or publication status require justification and assessment of the direction in which evidence might be missed.

Backward references, forward citations, related-record searches, and expert contact may supplement electronic retrieval but need recorded rules and dates. An experienced information specialist should independently review major strategies where feasible, and known key studies can test recall. Records should enter through stable identifiers with original batches, deduplication logic, and duplicate links retained. A protocol, registration, abstract, primary report, secondary analysis, correction, and other reports from one study should form a study family so that multiple papers are not counted as multiple studies. Retractions, corrections, and expressions of concern should be checked before inclusion and at updates.

Screening, extraction, and risk of bias

Title–abstract and full-text screening should use piloted criteria with enough independent judgment and conflict resolution to control error. If a rapid method uses one reviewer or sampled verification, its rationale and missed-study risk require disclosure. A flow diagram should show identification, deduplication, screening, full-text assessment, exclusion reasons, and final inclusion. Unavailable full texts, translation, insufficient information, and duplicate publication need defined handling. Studies must not be excluded because results are null or unwelcome. Machine ranking may order work, but an unvalidated stopping rule should not silently replace human eligibility decisions.

Extraction forms should be organized by study rather than paper, piloted, and capture population, design, sample size, exposure or intervention, comparator, instrument, time point, outcome definition, values, adjustment factors, funding, and conflicts. Derived values, graph readings, unit conversions, and author contact need audit trails, with critical results checked by another person. Risk-of-bias tools should fit the question and design and provide reasoned judgments for specific results rather than one quality score. Randomized, nonrandomized intervention, diagnostic, prediction, prevalence, and review-level evidence need different tools, and poor reporting should be distinguished from demonstrated high bias.

Synthesis, heterogeneity, and certainty

Meta-analysis depends on sufficient compatibility in populations, interventions or exposures, comparators, outcomes, and designs—not merely the presence of two studies. Effect direction, time point, and units should be harmonized before pooling, while overlapping populations, multiarm trials, crossover designs, and correlated outcomes must not be counted repeatedly. Models, effect measures, and variance methods should fit the data. Statistical heterogeneity needs interpretation alongside clinical and methodological differences; a random-effects model does not remove heterogeneity. Subgroup, meta-regression, sensitivity, and small-study analyses should be prespecified and acknowledged as unstable when few studies are available.

When pooling is not defensible, structured methods should group studies, present effects, and explain differences rather than count “positive” and “negative” papers or vote by statistical significance. Reports should show effect estimates, intervals, absolute effects, missing and harmful outcomes, and evaluate selective reporting and missing evidence. Certainty belongs to a body of evidence for a defined outcome and considers within-study bias, inconsistency, indirectness, imprecision, and publication bias; it is not a simple score based on journal rank or study label. If a scoping review omits bias or certainty assessment, it should state that its conclusions cannot carry comparative efficacy claims.

Interpretation specific to sleep evidence

Sleep studies often combine diaries, questionnaires, actigraphy, home sleep apnea testing, and polysomnography, while identically named variables may differ by device algorithm, scoring version, unit, and time window. Reviews should separate subjective quality, sleep latency, efficiency, stages, apnea–hypopnea index, oxygenation, arousals, sleepiness, and quality of life and verify whether higher values mean improvement or worsening. Treatment dose, follow-up duration, baseline severity, age, shift work, and comorbidity can change comparability. Night-level records should not be mistaken for independent participants.

Circadian evidence also depends on clock time, time zone, sleep phase, light, meals, and duration awake; one morning specimen cannot be combined with dense rhythmic sampling to infer an endogenous rhythm. Experimental sleep deprivation, clinical insomnia, obstructive sleep apnea, and habitual short sleep provide different evidence, as do human, animal, and in-vitro studies. Statistical significance is not clinical importance, and change in a surrogate does not guarantee benefit in an outcome important to patients. Moving from synthesis to a clinical recommendation additionally requires benefit–harm, values, feasibility, and resource judgments rather than a recommendation issued directly by the review service.

Delivery, automation, and continuing updates

The delivery package may include the protocol and amendments, registration, source list, complete strategies and search log, deduplicated library, screening decisions and full-text exclusion reasons, study-family mapping, extraction tables, bias judgments, analysis code, figures, evidence summaries, certainty explanations, and report. Data and scripts should be shared only within copyright, license, subscription, and personal-information constraints. Citation does not replace checking the source and does not permit wholesale copying of protected text. The commissioner should receive the date, version, evidence cutoff, and known unresolved information so that an old review is not mistaken for current fact.

Automation, machine learning, and generative tools may assist deduplication, ranking, format conversion, candidate extraction, or consistency checks, but their versions, inputs, thresholds, validation samples, errors, and human review must be auditable. Generated summaries and invented citations are not source evidence. A living review needs prespecified surveillance frequency, inclusion triggers, reanalysis, version release, and retirement rules; an ordinary review should state when updating may be needed. Quality oversight covers training, agreement in duplicate judgments, data changes, code review, backup, and defect correction. Quality is demonstrated by a question-fit method, reproducible search, traceable judgments, and conclusions proportional to evidence—not the largest possible paper count.